Close Menu

This story has been updated to include information from Twist's Q3 investor call.

NEW YORK – Twist Bioscience reported a 56 percent increase in third quarter fiscal year 2020 revenues after the close of the market on Thursday.

For the quarter ended June 30, 2020, Twist reported $21.2 million in revenues, up from $13.6 million during the same period last year, beating Wall Street analysts' average revenue estimate of $14.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.